MarketCap
Facebook
X
TelegramQuarterly report 2024-Q1
added 05-14-2024
Country |
 Israel |
IPO year |
2018 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
1.55 M |
Market Cap[1] |
$ 263 K |
EBITDA (LTM) |
$ -11 M |
P/E (LTM) |
- |
P/S (LTM) |
0.82 |
EPS (LTM) |
-6.48 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Co-Diagnostics
CODX
|
$ 1.67 | - | $ 2.22 M | Nasdaq Capital Market |  USA |
 |
Castle Biosciences
CSTL
|
$ 24.46 | - | $ 679 M | Nasdaq Global Market,SPB | USA |
 |
Agilent Technologies
A
|
$ 115.55 | - | $ 35.1 B | NYSE,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 127.88 | - | $ 20.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 84.33 | - | $ 5.69 B | Nasdaq Global Select Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Koninklijke Philips N.V.
PHG
|
$ 27.47 | - | $ 20 B | NYSE |  Niderland |
 |
CareDx, Inc
CDNA
|
$ 21.23 | - | $ 1.13 B | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Senseonics Holdings
SENS
|
$ 7.05 | - | $ 294 M | NYSE American | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 16.31 | - | $ 493 M | Nasdaq Global Market | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 469.71 | - | $ 177 B | NYSE,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Trinity Biotech plc
TRIB
|
$ 0.65 | -1.84 % | $ 61.9 M | Nasdaq Global Select Market |  Irlanda |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Twist Bioscience Corporation
TWST
|
$ 60.94 | - | $ 3.64 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 169.8 | - | $ 8.42 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Guardant Health
GH
|
$ 88.91 | - | $ 11.1 B | Nasdaq Global Select Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.98 | -2.37 % | $ 8.76 M | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 410.54 | - | $ 11.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Exagen
XGN
|
$ 2.7 | 0.75 % | $ 58.2 M | Nasdaq Global Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Neogen Corporation
NEOG
|
$ 9.54 | - | $ 2.07 B | Nasdaq Global Select Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.14 | - | $ 4.92 M | Nasdaq Capital Market | USA |
 |
National Research Corporation
NRC
|
$ 17.23 | - | $ 386 M | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 102.17 | - | $ 8.43 B | Nasdaq Global Select Market,SPB | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
$ 263.8 | - | $ 21.9 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 121.03 | - | $ 5.66 B | Nasdaq Global Select Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
NeoGenomics
NEO
|
$ 8.29 | - | $ 1.06 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.78 | - | $ 443 M | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 203.75 | - | $ 20.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 196.27 | - | $ 21.8 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.